MIST

Milestone Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 3/10
  • Momentum↓ 3/10
Milestone Pharmaceuticals sales and earnings growth
MIST Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -1.23%
  • FCF Y/Y↓ -35.51%
Milestone Pharmaceuticals gross and profit margin trends
MIST Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -73.30%
Milestone Pharmaceuticals net debt vs free cash flow
MIST Risk
Fair
  • Debt / Equity↑ 2.8
  • Debt / FCF↓ 0.2
  • Interest coverage↓ -14.4

Milestone Pharmaceuticals stock volatility is in-line with the overall market. We give it a Fair risk rating.

More Biotechnology stocks ↗